Articles On Virtus Health (ASX:VRT)

Two weeks after Virtus Health signed a two-headed takeover with European buyout firm CapVest, questions are being asked about the deal’s underlying value. 

CapVest Partners has written approval from the Foreign Investment Review Board (FIRB) that the Federal Government has no objection to the proposed acquisition of Virtus Health (VRT) The confirmation satisfies the FIRB condition in the tran...

The ASX microcaps Emerging Companies index closed 0.01% higher on Friday Copper explorer Stelar Metals (ASX:SLB) led the market with a 57% gain US stock futures are trading flat ahead of the Friday open on Wall St   After a pretty strong...

The share market sealed back-to-back weekly gains with a fourth straight advance after strong economic data and a pause in energy prices lifted Wall Street. The S&P/ASX 200 climbed 19 points or 0.26 per cent. The rally lifted the ben...

A rebound on Wall Street helped propel the ASX towards a fourth straight gain as a two-week mining rally rolled on. The S&P/ASX 200 climbed 38 points or 0.52 per cent by mid-session. The rally lifted the benchmark above 7400 for the...

Highlights Dividends are typically published a few weeks before the ex-dividend date. Investors should buy shares before the ex-dividend day to receive dividends as an eligible shareholder. Some notable companies like Myer Holdings an...

The Virtus Health Ltd (ASX: VRT) share price is hovering in negative territory in early afternoon trade on Wednesday. This is despite the All Ordinaries Index (ASX: XAO) shooting higher today by 0.45% to 7,655 points. At the time of writin...

The Virtus Health Ltd (ASX: VRT) share price is seesawing today. It has been down as low as $8.21 and as high as $8.27 but it is currently 0.12% in the red at $8.22. This comes despite the fertility treatment company not releasing any pric...

Wall Street’s best week since 2020 points to further gains for Australian investors as market sentiment continues to recover. The S&P/ASX 200 was set to open 59 points or 0.81 per cent higher, according to futures action. An open at...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. At the start of trade on Frida...

There’s one item that dealmakers can strike off their M&A playbooks after the tussle for Virtus Health: getting boards to agree to no talks without a fiduciary out.

Virtus Health (VRT) announces its transaction implementation deed (TID) with CapVest Partners which will take 100 per cent control of Virtus by a scheme arrangement The binding agreement is a two-tiered offer, beginning with a scheme of ar...

Renewed optimism about Russia-Ukraine peace talks helped curb soaring commodity prices and lift Australian shares to their highest in more than a week. The S&P/ASX 200 rallied 86 points or 1.21 per cent as rising US equity futures sh...

The Virtus Health Ltd (ASX: VRT) share price is soaring more than 7% higher on Monday after the release of a company announcement. Shares in the reproductive health company and day surgery provider had been on ice since Friday pending an a...

After three months of bids the board of in-vitro fertilisation (IVF) company Virtus Health (ASX: VRT) has agreed to a takeover offer from UK private equity firm CapVest for $706 million, amidst "overwhelming support" from the group's fertil...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week on a positive note. At the time of writing, the benchmark index is up 1% to 7,134.5 points. Four ASX shares that are climbing more than most today are...

The share market reversed Friday’s loss as reports of progress in Russia-Ukraine peace talks boosted US equity futures and drove down the price of oil. The S&P/ASX 200 rallied 83 points or 1.18 per cent by mid-session. Ten of 11 s...

Highlights The benchmark ASX 200 was trading 0.88% up at 7,125 in the first 15 minutes of trading on Monday. Major US stock indices ended lower on Friday as technology and growth shares fell sharply. All 11 sectors are trading higher...

14 Mar 2022 - Virtus Health (ASX:VRT) has accepted a takeover bid from CapeVest despite receiving a rival bid from BGH Capital.

US FDA approves EBR’s wireless pacemakers Singular Health and Osteopore to pursue US FDA and TGA approvals Virtus Heath to be acquired and de-listed The ASX 200 Health Index (XHJ) is trading higher by 1.5% at the time of writing, compared...

Virtus Health has signed a binding deal with CapVest at $8.25 a share.

ASX jumps with broad gains led by health, shrugging off falls on Wall St. Magellan hits 7.5 year low, CapVest to buy Virtus Health and Elders leaps on earnings update.

A volatile week ended with a loss as investors reassessed the risks of rising costs derailing the post-pandemic global rebound.   The S&P/ASX 200 fell 67 points or 0.94 per cent today. The decline sealed a weekly loss of 47 points or...

The Virtus Health Ltd (ASX: VRT) share price is currently halted after the company requested a trading pause before the market open today. Virtus Health shares have posted solid gains so far in 2022, having shot up more than 26% over the p...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Through the destruction of war...

The share market’s push for a third straight gain floundered as strength in mining stocks was outweighed by weakness across the wider market. A 21-point opening rally gave way to a mid-session loss of 58 points or 0.82 per cent on the S&...

ShareCafeThe Week that Was – February 28-March 4, 2022 We at ShareCafe understand you are busy and may not have been left with enough time to keep up with the quality content we’ve been bringing you throughout the week. To make it easier to...

The Australian share market continued the post-invasion recovery, with the S&P/ASX 200 (ASX: XJO) gaining 0.7% to begin the month of March; this comes after finishing February just 1.1% higher. The ASX technology sector was the biggest...

Australian stocks rose for a third session after the Reserve Bank renewed its pledge to be patient on rates, citing the war in Ukraine as “a major new source of uncertainty”. The S&P/ASX 200 rallied into the 2.30 pm RBA announcement...

01 Mar 2022 - CapVest has improved its takeover offer for Virtus Health (ASX:VRT), while stepping on BGH Capital’s upgraded offer from yesterday.

Australian stocks rose for a third day as buyers continued to discount the threat of significant economic fallout from the Russia-Ukraine crisis. The S&P/ASX 200 rallied 86 points or 1.22 per cent, supported by tentatively positive U...

Highlights The benchmark ASX 200 surged 1.1% to 79.3 points in the first 15 minutes of trading. The Russian ruble hit an all-time low on Monday with Russia hit by a bombardment of Western sanctions. The IT sector is buzzing with a 4.4...

The board of fertility multinational Virtus Health (ASX: VRT) has decided not to engage with BGH Capital regarding its revised proposal yesterday to acquire the business for $7.65 per share. The decision comes after CapVest Partners spiced...

ShareCafeCustody Battle Drags on for Virtus Health The battle for IVF operator Virtus Health continues with Australian private equity group BGH upping its offer price as it goes head-to-head with London based rival CapVest. Virtus briefly e...

Highlights The Australian share market closed higher today, despite Western nations ramping up sanctions against Russia as the conflict boils further. Asian stock markets traded lower. Investors now await Wall Street’s opening perform...

Risk-off moves on global financial markets curbed a second day of share-market gains as investors fretted about the economic fallout from the Russia-Ukraine crisis. The S&P/ASX 200 climbed 51 points or 0.73 per cent. The last maj...

After successfully preventing rival suitor CapVest from entering a formal deal to acquire Virtus Health (ASX: VRT) before 11 March, BGH Capital has upped the ante in its attempt to take over the Sydney-headquartered fertility multinational....

28 Feb 2022 - Reproductive technology and IVF specialist Virtus Health (ASX:VRT) has received a revised takeover bid from BGH Capital.

Highlights The benchmark ASX 200 was up 0.6% to 7,034.9 in the first 15 minutes of trading. On the ASX, eight out of the 11 sectors were trading in the green today. Global markets could be setting for another volatile week in light of...

Australian stocks rose for a second session, hampered by a slump in US futures after the West turned the screws on Russia’s economy. The S&P /ASX 200 climbed 36 points or 0.52 per cent by mid-session. Oil producers, grain companie...

BGH Capital’s had the weekend to stew on its Takeovers Panel victory at Virtus Health, and it is understood to have a superior proposal in the works.

World Overnight SPI Overnight 7028.00 – 90.00 – 1.26% S&P ASX 200 7205.70 + 44.40 0.62% S&P500 4225.50 – 79.26 – 1.84% Nasdaq Comp 13037.49 – 344.03 – 2.57% DJIA 33131.76 – 464.85 – 1.38% S&P500 VIX 31.02 + 2.21 7....

Melbourne buyout firm BGH Capital will claim victory at the Takeovers Panel after a marathon three-week hearing to decide the fate of ASX-listed Virtus Health. 

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AX1)) - Accent Group ((AWC)) - Alumina Ltd ((ARB)) - ARB Corp ((AUB)) - AUB Group ((BST)) - Best & Less ((COH)) - Cochlear ((COL)) - Coles Group ((CGC)) - Costa Grou...

The share market closed at a two-week low after a dramatic escalation in the Russia-Ukraine crisis triggered sharp declines on Asian markets and US futures. The S&P/ASX 200 skidded 72 points or 1 per cent to 7161. Today’s close was t...

Australian stocks fell to two-week low as part of a global retreat from risk after Russia sent troops into separatist-held parts of Ukraine. The S&P/ASX 200 dropped as low as 7133.5 before trimming its loss to 78 points or 1.07 per c...

Shares in Virtus Health Ltd (ASX: VRT) are on the move today after the company released its interim report and financial results for the half-year ended 31 December 2021. At the time of writing, the Virtus Health share price is trading do...

Highlights The benchmark ASX 200 tumbled 1% to 7,165 in the first 15 minutes of trading. US markets were closed on Monday on account of Presidents’ Day. On Monday, Russian forces claimed to kill a group of five saboteurs which breache...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. First a note on things are are...

We go over the key stocks we are looking out for in the Healthcare sector this February Reporting Season. Stocks include; ResMed Inc (ASX:RMD), Pro Medicus (ASX:PME), Healius (ASX:HLS), Virtus Health (ASX:VRT), Monash IVF (ASX:MVF), and CSL...